TCL Archive In Brief: Louisville Cancer Center Developed With No Federal, State Money Or Fund Raising Costs May 30, 1980
TCL Archive PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III November 28, 2014